SuperworthWest Pharmaceutical Services EPS WST
Diluted earnings per share by quarter and over the last twelve months, from 2009.
- Last 12 months, to Jun 30, 2026
- $7.81
- Latest quarter, Q2 FY26
- $2.15
- +18% on a year earlier
- Fiscal year 2025
- $6.79
- +2% on the year before
West Pharmaceutical Services' earnings per share was $7.81 over the twelve months to Jun 30, 2026, up 17% on a year earlier.
In its latest quarter, Q2 FY26, it was $2.15, up 18% on the same quarter a year before.
Over the five fiscal years to FY2025 it grew 8% a year on average.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $6.79 | +2% |
| FY2024 | $6.68 | −15% |
| FY2023 | $7.88 | +2% |
| FY2022 | $7.72 | −11% |
| FY2021 | $8.67 | +89% |
| FY2020 | $4.58 | +43% |
| FY2019 | $3.20 | +16% |
| FY2018 | $2.75 | +38% |
| FY2017 | $1.99 | +4% |
| FY2016 | $1.92 | +48% |
| FY2015 | $1.30 | −26% |
| FY2014 | $1.76 | +12% |
| FY2013 | $1.57 | +38% |
| FY2012 | $1.14 | +7% |
| FY2011 | $1.06 | +15% |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $2.15 | +18% | $7.81 | |
| Q1 FY26 | $1.92 | +56% | $7.48 | |
| Q4 FY25 | $1.82 | +3% | $6.79 | |
| Q3 FY25 | $1.92 | +4% | $6.74 | |
| Q2 FY25 | $1.82 | +21% | $6.67 | |
| Q1 FY25 | $1.23 | −21% | $6.36 | |
| Q4 FY24 | $1.77 | −3% | $6.68 | |
| Q3 FY24 | $1.85 | −14% | $6.74 | |
| Q2 FY24 | $1.51 | −27% | $7.03 | |
| Q1 FY24 | $1.55 | −16% | $7.58 | |
| Q4 FY23 | $1.83 | +35% | $7.88 | |
| Q3 FY23 | $2.14 | +35% | $7.41 |
Against its peers
Companies in Medical - Instruments & Supplies nearest West Pharmaceutical Services' size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| WSTWest Pharmaceutical Services | $7.81 | +17% a year |
| RMDResMed | $10.43 | +10% a year |
| MDLNMedline | n/m | |
| SOLVSolventum | $8.18 | +277% a year |
| BDXBecton, Dickinson and | $3.31 | −40% a year |
| PENPenumbra | $4.07 | +8% a year |
| COOCooper Companies | $2.93 | +44% a year |
| ALGNAlign Technology | $5.75 | −3% a year |
| GMEDGlobus Medical | $3.91 | +50% a year |
| PODDInsulet | $5.35 | +64% a year |
| MSAMSA Safety | $8.04 | +15% a year |
| Peer median | $5.35 |
Where West Pharmaceutical Services ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on West Pharmaceutical Services
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.